stockrowBioMarin Pharmaceutical Inc.
BMRN Healthcare Biotechnology
BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- −296.6%
- Free cash flow
- −52.3%
- Total debt
- +599.5%
Quarter to September 2026, against a year earlier
Follow BMRN
Alert me
BioMarin Pharmaceutical Inc. (BMRN) Revenue growth
BioMarin Pharmaceutical Inc.'s revenue growth over the twelve months to 30 September 2026 was 18.1%, up 5.3 percentage points from fiscal 2025 (12.9%). Over the past ten years it has ranged from −0.76% (fiscal 2021) to 25.5% (fiscal 2016); the current reading is higher than 27% of that period. That is above the Biotechnology industry median of 6.26% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 12.9% | (5.10) |
| FY2024 | 18.0% | 2.55 |
| FY2023 | 15.4% | 1.89 |
| FY2022 | 13.5% | 14.29 |
| FY2021 | −0.76% | (9.94) |
| FY2020 | 9.18% | (5.09) |
| FY2019 | 14.3% | 0.75 |
| FY2018 | 13.5% | (4.10) |
| FY2017 | 17.6% | (7.88) |
| FY2016 | 25.5% | 6.73 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 32.0% | 12.11 |
| Jun 2026 | 19.9% | 17.08 |
| Mar 2026 | 2.83% | (14.20) |
| Dec 2025 | 17.0% | 12.95 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| IBRX ImmunityBio, Inc. compare | 192.9% |
| KYMR Kymera Therapeutics, Inc. compare | 134.8% |
| TGTX TG Therapeutics, Inc. compare | 76.1% |
| CAI Caris Life Sciences,�Inc. compare | 68.8% |
| TWST Twist Bioscience Corporation compare | 19.2% |
| BMRN BioMarin Pharmaceutical Inc. | 18.1% |
| TECH Bio-Techne Corp compare | −0.38% |
| SMMT Summit Therapeutics PLC compare | −61.0% |
| PCVX Vaxcyte, Inc. compare | — |
| Biotechnology industry median | 6.26% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BMRN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement